Project Details
Description
Evaluation of the Safety of Poziotinib in Combination With TDM1 in Women with Advanced or Metastatic HER2+ Breast Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 10/17/17 → 7/1/19 |
Funding
- SPECTRUM PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.